{"transactions":[{"id":4613394,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-09T20:30:03.000Z","date":"2026-09-04","kind":"sale","planned":false,"acquired":false,"shares":1600,"price":25.32,"value":40512.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction reflects a sale of ordinary shares to generate proceeds to satisfy the Reporting Person's tax obligations in connection with the prior vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.24 to $25.37 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 8,040 ordinary shares subject to restricted stock unit awards that remain subject to vesting."}],"balance_after":8760,"source":{"system":"sec-edgar","filing":"0001193125-26-386508","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526386508/ownership.xml","form_type":"4"}},{"id":697250,"issuer":{"id":4247,"kind":"organization","name":"MBX Biosciences, Inc."},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-08-04T12:51:27.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest and become exercisable with 25% of the shares subject to the award vesting on July 13, 2027 and the remainder vesting in 36 equal monthly installments thereafter, subject to continued service on each such vesting date."}],"balance_after":130000,"derivative":{"exercise_price":64.41,"expiration_date":"2036-08-03","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001193125-26-331642","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1776111/000119312526331642/ownership.xml","form_type":"4"}},{"id":697249,"issuer":{"id":4247,"kind":"organization","name":"MBX Biosciences, Inc."},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-04T12:51:27.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"). 25% of the shares subject to the RSU grant will vest annually over four years, on each July 13, 2027, 2028, 2029 and 2030, subject to continued service on each such vesting date."}],"balance_after":28000,"source":{"system":"sec-edgar","filing":"0001193125-26-331642","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1776111/000119312526331642/ownership.xml","form_type":"4"}},{"id":717575,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T20:35:21.000Z","date":"2026-07-01","kind":"sale","planned":false,"acquired":false,"shares":12000,"price":2.9082,"value":34898.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.9082, and the range of prices were between $2.87 and $2.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":91403,"source":{"system":"sec-edgar","filing":"0001493152-26-031927","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226031927/ownership.xml","form_type":"4"}},{"id":731831,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T23:05:11.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":31566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":31566,"derivative":{"exercise_price":3.03,"expiration_date":"2036-06-15","underlying":"Common stock","underlying_shares":31566},"source":{"system":"sec-edgar","filing":"0001493152-26-029413","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029413/ownership.xml","form_type":"4"}},{"id":731830,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T23:05:11.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":28409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":103403,"source":{"system":"sec-edgar","filing":"0001493152-26-029413","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029413/ownership.xml","form_type":"4"}},{"id":942363,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2026-01-10T00:33:38.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":15300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the ordinary shares underlying the option will vest on January 2, 2027, the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date."}],"balance_after":15300,"derivative":{"exercise_price":35.45,"expiration_date":"2036-01-07","underlying":"Ordinary Shares","underlying_shares":15300},"source":{"system":"sec-edgar","filing":"0001193125-26-009270","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526009270/ownership.xml","form_type":"4"}},{"id":942362,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-10T00:33:38.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":3400,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. All of the RSUs will vest on the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on January 7, 2026 for no consideration."}],"balance_after":10360,"source":{"system":"sec-edgar","filing":"0001193125-26-009270","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526009270/ownership.xml","form_type":"4"}},{"id":1052716,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-29T20:30:54.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":28576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":28576,"derivative":{"exercise_price":3.64,"expiration_date":"2035-08-26","underlying":"Common stock","underlying_shares":28576},"source":{"system":"sec-edgar","filing":"0001641172-25-026005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026005/ownership.xml","form_type":"4"}},{"id":1052715,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-29T20:30:54.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":22283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":74994,"source":{"system":"sec-edgar","filing":"0001641172-25-026005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026005/ownership.xml","form_type":"4"}},{"id":1306920,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-01-08T23:09:41.000Z","date":"2025-01-06","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the shares underlying the option will vest on January 6, 2026, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for two years, subject to the Reporting Person's continued service through each such date."}],"balance_after":32500,"derivative":{"exercise_price":25.85,"expiration_date":"2035-01-06","underlying":"Ordinary Shares","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0000950170-25-003570","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000095017025003570/ownership.xml","form_type":"4"}},{"id":1306919,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-01-08T23:09:41.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":6960,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on January 7, 2025 for no consideration."}],"balance_after":6960,"source":{"system":"sec-edgar","filing":"0000950170-25-003570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000095017025003570/ownership.xml","form_type":"4"}},{"id":1319703,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Right to Buy)","published_at":"2024-12-31T18:20:07.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":50469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":50469,"derivative":{"exercise_price":1.96,"expiration_date":"2034-07-31","underlying":"Common Stock","underlying_shares":50469},"source":{"system":"sec-edgar","filing":"0001415889-24-030275","document":"form4a-12312024_011203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924030275/form4a-12312024_011203.xml","form_type":"4/A","original_submission_date":"2024-08-05"}},{"id":1440553,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Right to Buy)","published_at":"2024-08-05T22:34:58.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":50469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":50469,"derivative":{"exercise_price":1.54,"expiration_date":"2034-07-31","underlying":"Common Stock","underlying_shares":50469},"source":{"system":"sec-edgar","filing":"0001415889-24-020778","document":"form4-08052024_100852.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924020778/form4-08052024_100852.xml","form_type":"4"}},{"id":1440552,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T22:34:58.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":39541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":52711,"source":{"system":"sec-edgar","filing":"0001415889-24-020778","document":"form4-08052024_100852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924020778/form4-08052024_100852.xml","form_type":"4"}},{"id":1486437,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant (Right to Buy)","published_at":"2024-06-08T01:45:18.000Z","date":"2024-05-29","kind":"purchase","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock.  The combined price of each share of common stock offered together with one warrant was $4.00."}],"balance_after":6250,"derivative":{"exercise_price":5.25,"exercise_date":"2024-05-29","expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001415889-24-016109","document":"form4-06072024_090615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924016109/form4-06072024_090615.xml","form_type":"4"}},{"id":1486436,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-08T01:45:18.000Z","date":"2024-05-29","kind":"purchase","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock.  The combined price of each share of common stock offered together with one warrant was $4.00."}],"balance_after":13170,"source":{"system":"sec-edgar","filing":"0001415889-24-016109","document":"form4-06072024_090615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924016109/form4-06072024_090615.xml","form_type":"4"}},{"id":1640630,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-15T23:23:45.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25718,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 3, 2021, and received in exchange for the option, these RSUs that vest in eight equal quarterly installments commencing May 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":32.44,"expiration_date":"2025-03-31","underlying":"Common Stock","underlying_shares":25718},"source":{"system":"sec-edgar","filing":"0001787306-24-000014","document":"wk-form4_1708039415.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000178730624000014/wk-form4_1708039415.xml","form_type":"4"}},{"id":1640629,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-15T23:23:45.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8379,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on February 27, 2020, and received in exchange for the option,  these Restricted Stock Units (\"RSUs\") that vest in four equal quarterly installments commencing May 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":27.61,"expiration_date":"2025-03-31","underlying":"Common Stock","underlying_shares":8379},"source":{"system":"sec-edgar","filing":"0001787306-24-000014","document":"wk-form4_1708039415.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000178730624000014/wk-form4_1708039415.xml","form_type":"4"}},{"id":1640628,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-15T23:23:45.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":8572,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 3, 2021, and received in exchange for the option, these RSUs that vest in eight equal quarterly installments commencing May 1, 2024."}],"balance_after":11365,"source":{"system":"sec-edgar","filing":"0001787306-24-000014","document":"wk-form4_1708039415.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000178730624000014/wk-form4_1708039415.xml","form_type":"4"}},{"id":1640627,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-15T23:23:45.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":2793,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on February 27, 2020, and received in exchange for the option,  these Restricted Stock Units (\"RSUs\") that vest in four equal quarterly installments commencing May 1, 2024."}],"balance_after":2793,"source":{"system":"sec-edgar","filing":"0001787306-24-000014","document":"wk-form4_1708039415.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000178730624000014/wk-form4_1708039415.xml","form_type":"4"}},{"id":1693372,"issuer":{"id":1826,"kind":"organization","name":"NewAmsterdam Pharma Co N.V.","symbol":"NAMS"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-01-03T22:13:26.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option will vest on January 1, 2025, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date."}],"balance_after":10000,"derivative":{"exercise_price":11.17,"expiration_date":"2034-01-01","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-24-001112","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000095017024001112/ownership.xml","form_type":"4"}},{"id":1698751,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-28T17:38:19.000Z","date":"2023-12-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, this option was exchanged for an option covering 2,662 shares of Cyclo Common Stock."}],"balance_after":0,"derivative":{"exercise_price":0.34,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-059940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123059940/doc4.xml","form_type":"4"}},{"id":1698750,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-28T17:38:19.000Z","date":"2022-05-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated as of September 21, 2023 (the \"Merger Agreement\"), by and among Cyclo Therapeutics, Inc. (\"Cyclo\"), Cameo Merger Sub, Inc. and the Issuer, at the effective time of the merger, each outstanding option with an exercise price of $0.40 or more was cancelled effective as of the closing."}],"balance_after":0,"derivative":{"exercise_price":3.13,"expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-059940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123059940/doc4.xml","form_type":"4"}},{"id":1698749,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-28T17:38:19.000Z","date":"2023-12-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger dated as of September 21, 2023 (the \"Merger Agreement\"), by and among Cyclo Therapeutics, Inc. (\"Cyclo\"), Cameo Merger Sub, Inc. and the Issuer, at the effective time of the merger, each outstanding option with an exercise price of $0.40 or more was cancelled effective as of the closing."}],"balance_after":0,"derivative":{"exercise_price":8.01,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-23-059940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123059940/doc4.xml","form_type":"4"}},{"id":1780890,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-15T00:18:41.000Z","date":"2023-09-13","kind":"sale","planned":false,"acquired":false,"shares":900,"price":20.78,"value":18702.0,"ownership":{"direct":true},"balance_after":6920,"source":{"system":"sec-edgar","filing":"0001209191-23-049519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123049519/doc4.xml","form_type":"4"}},{"id":1781897,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-14T00:14:26.000Z","date":"2023-09-11","kind":"grant","planned":false,"acquired":true,"shares":8447,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest in equal monthly installments over a three year period following the date of grant."}],"balance_after":8447,"derivative":{"exercise_price":22.4,"expiration_date":"2033-09-10","underlying":"Common Stock","underlying_shares":8447},"source":{"system":"sec-edgar","filing":"0001209191-23-049364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123049364/doc4.xml","form_type":"4"}},{"id":1781896,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-14T00:14:26.000Z","date":"2023-09-11","kind":"grant","planned":false,"acquired":true,"shares":6920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs shall vest in equal monthly installments over a three year period following the date of grant."}],"balance_after":7820,"source":{"system":"sec-edgar","filing":"0001209191-23-049364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000120919123049364/doc4.xml","form_type":"4"}},{"id":1788793,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-06T01:38:43.000Z","date":"2023-08-31","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/48 of the total shares in equal monthly installments over a four year period, beginning September 30, 2023, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase."}],"balance_after":125000,"derivative":{"exercise_price":8.54,"expiration_date":"2033-08-31","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001787306-23-000088","document":"wk-form4_1693964312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000178730623000088/wk-form4_1693964312.xml","form_type":"4"}},{"id":1846186,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-23T00:16:58.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest in full on the earlier to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":0.8152,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-039205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000120919123039205/doc4.xml","form_type":"4"}},{"id":1854517,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T17:28:46.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the stock option granted on June 14, 2023 will become vested on the earlier of (i) June 14, 2024 or (ii) the business day prior to the date of the 2024 annual meeting of stockholders."}],"balance_after":20000,"derivative":{"exercise_price":0.34,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-037454","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919123037454/doc4.xml","form_type":"4"}},{"id":2047275,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-24T21:15:47.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":36875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in substantially equal monthly installments over 12 months, commencing on January 20, 2023, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":36875,"derivative":{"exercise_price":0.4688,"expiration_date":"2033-01-19","underlying":"Common Stock","underlying_shares":36875},"source":{"system":"sec-edgar","filing":"0001209191-23-004591","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000120919123004591/doc4.xml","form_type":"4"}},{"id":2233688,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-13T22:51:07.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest in full on the earlier to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":1.65,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-036453","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000120919122036453/doc4.xml","form_type":"4"}},{"id":2255378,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T17:23:13.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the stock option granted on May 24, 2022 will become vested on the earlier of (i) May 24, 2023 or (ii) the business day prior to the date of the 2023 annual meeting of stockholders."}],"balance_after":20000,"derivative":{"exercise_price":3.13,"expiration_date":"2032-05-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-032280","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122032280/doc4.xml","form_type":"4"}},{"id":2421175,"issuer":{"id":95737,"kind":"organization","name":"Applied Molecular Transport Inc.","symbol":"AMTI"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-31T17:39:48.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1/36th of the shares subject to the option will become vested and exercisable on the Exercisable Date set forth above and 1/36th of the shares subject to the option shall continue to vest each month thereafter, provided that Reporting Person is a service provider to the Issuer as of each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":8.01,"exercise_date":"2022-02-27","expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-22-005705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801777/000120919122005705/doc4.xml","form_type":"4"}},{"id":2545277,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-08T21:18:52.000Z","date":"2021-10-06","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on August 25, 2021, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":11.36,"expiration_date":"2031-10-05","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-060072","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000120919121060072/doc4.xml","form_type":"4"}},{"id":2587754,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Earn-out Right","published_at":"2021-08-27T22:26:30.000Z","date":"2021-08-25","kind":"grant","acquired":true,"shares":3556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each earn-out right represents a contingent right to receive one share of the Issuer's common stock. Pursuant to an \"Earn-Out\" provision in the Merger Agreement, the earn-out rights vest upon the Issuer's common stock achieving a price per share which equals or exceeds $20.00 over at least 20 trading days out of a 30 consecutive trading day period prior to August 26, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"Each earn-out right represents a contingent right to receive one share of the Issuer's common stock. Pursuant to an \"Earn-Out\" provision in the Merger Agreement, the earn-out rights vest upon the Issuer's common stock achieving a price per share which equals or exceeds $20.00 over at least 20 trading days out of a 30 consecutive trading day period prior to August 26, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each earn-out right represents a contingent right to receive one share of the Issuer's common stock. Pursuant to an \"Earn-Out\" provision in the Merger Agreement, the earn-out rights vest upon the Issuer's common stock achieving a price per share which equals or exceeds $20.00 over at least 20 trading days out of a 30 consecutive trading day period prior to August 26, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each earn-out right represents a contingent right to receive one share of the Issuer's common stock. Pursuant to an \"Earn-Out\" provision in the Merger Agreement, the earn-out rights vest upon the Issuer's common stock achieving a price per share which equals or exceeds $20.00 over at least 20 trading days out of a 30 consecutive trading day period prior to August 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each earn-out right represents a contingent right to receive one share of the Issuer's common stock. Pursuant to an \"Earn-Out\" provision in the Merger Agreement, the earn-out rights vest upon the Issuer's common stock achieving a price per share which equals or exceeds $20.00 over at least 20 trading days out of a 30 consecutive trading day period prior to August 26, 2023."}],"balance_after":3556,"derivative":{"underlying":"Common Stock","underlying_shares":3556},"source":{"system":"sec-edgar","filing":"0001209191-21-053707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000120919121053707/doc4.xml","form_type":"4"}},{"id":2587753,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-27T22:26:30.000Z","date":"2021-08-25","kind":"grant","acquired":true,"shares":24142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"At the Effective Time, each outstanding option to purchase shares of old eFFECTOR common stock (each an \"old eFFECTOR Option\") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer equal to (i) the number of shares of old eFFECTOR common stock subject to the applicable old eFFECTOR Option multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests 25% on March 22, 2019, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":24142,"derivative":{"exercise_price":1.97,"expiration_date":"2028-03-26","underlying":"Common Stock","underlying_shares":24142},"source":{"system":"sec-edgar","filing":"0001209191-21-053707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000120919121053707/doc4.xml","form_type":"4"}},{"id":2587752,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-27T22:26:30.000Z","date":"2021-08-25","kind":"grant","acquired":true,"shares":24142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of May 26, 2021 (the \"Merger Agreement\"), by and among the Issuer (f/k/a Locust Walk Acquisition Corp.), Locust Walk Merger Sub, Inc. (\"Merger Sub\"), and eFFECTOR Therapeutics, Inc. (\"Old eFFECTOR\"), Merger Sub merged with and into Old eFFECTOR with Old eFFECTOR surviving as a wholly owned subsidiary of the Issuer (the \"Merger\"). Upon consummation of the Merger (the \"Effective Time\"), each issued and outstanding share of common stock of Old eFFECTOR was automatically cancelled and converted into approximately 0.09657 (the \"Exchange Ratio\") shares of common stock of the Issuer."}],"balance_after":24142,"source":{"system":"sec-edgar","filing":"0001209191-21-053707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000120919121053707/doc4.xml","form_type":"4"}},{"id":2794135,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-11T20:59:57.000Z","date":"2021-03-10","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase."}],"balance_after":44982,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-05-14","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001567619-21-006086","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921006086/doc1.xml","form_type":"4"}},{"id":2794134,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-11T20:59:57.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":1250,"price":32.9,"value":41125.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by The 1994 Smither Family Trust, as Amended and Restated in 2014, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":86715,"source":{"system":"sec-edgar","filing":"0001567619-21-006086","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921006086/doc1.xml","form_type":"4"}},{"id":2794133,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-11T20:59:57.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":500,"price":32.9,"value":16450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,250 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":46321,"source":{"system":"sec-edgar","filing":"0001567619-21-006086","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921006086/doc1.xml","form_type":"4"}},{"id":2794132,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-11T20:59:57.000Z","date":"2021-03-10","kind":"exercise","acquired":true,"shares":500,"price":1.6806,"value":840.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,250 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":46821,"source":{"system":"sec-edgar","filing":"0001567619-21-006086","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921006086/doc1.xml","form_type":"4"}},{"id":2805367,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-05T20:55:24.000Z","date":"2021-03-04","kind":"exercise","acquired":false,"shares":12396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects cash exercise of stock option without the disposition of the underlying shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/4th of the shares subject to the option vest on the one year anniversary measured from May 1, 2019 (the \"Vesting Commencement Date\"), and 1/48th of the shares vest monthly thereafter such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.  The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase."}],"balance_after":97684,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-05-14","underlying":"Common Stock","underlying_shares":12396},"source":{"system":"sec-edgar","filing":"0001567619-21-005736","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921005736/doc1.xml","form_type":"4"}},{"id":2805366,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-05T20:55:24.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":28800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from March 3, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":28800,"derivative":{"exercise_price":32.44,"expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":28800},"source":{"system":"sec-edgar","filing":"0001567619-21-005736","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921005736/doc1.xml","form_type":"4"}},{"id":2805365,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-05T20:55:24.000Z","date":"2021-03-04","kind":"exercise","acquired":true,"shares":12396,"price":1.6806,"value":20832.7176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects cash exercise of stock option without the disposition of the underlying shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,250 RSUs."}],"balance_after":46321,"source":{"system":"sec-edgar","filing":"0001567619-21-005736","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921005736/doc1.xml","form_type":"4"}},{"id":2805364,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-05T20:55:24.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on March 3 of each year, beginning March 3, 2022, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,250 RSUs."}],"balance_after":33925,"source":{"system":"sec-edgar","filing":"0001567619-21-005736","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921005736/doc1.xml","form_type":"4"}},{"id":2811526,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-03T21:48:47.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":773,"price":34.204,"value":26439.692,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\"). Shares and RSUs remain subject to a lock-up agreement with the underwriters for the Issuer's follow-on offering in February 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,750 RSUs. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":24425,"source":{"system":"sec-edgar","filing":"0001567619-21-005540","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921005540/doc1.xml","form_type":"4"}},{"id":2862463,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-12T22:32:40.000Z","date":"2021-02-10","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase."}],"balance_after":45482,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-05-14","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001567619-21-003626","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921003626/doc1.xml","form_type":"4"}},{"id":2862462,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-12T22:32:40.000Z","date":"2021-02-10","kind":"sale","acquired":false,"shares":2000,"price":35.64,"value":71280.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by The 1994 Smither Family Trust, as Amended and Restated in 2014, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":87965,"source":{"system":"sec-edgar","filing":"0001567619-21-003626","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921003626/doc1.xml","form_type":"4"}},{"id":2862461,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-12T22:32:40.000Z","date":"2021-02-10","kind":"sale","acquired":false,"shares":750,"price":35.64,"value":26730.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,000 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":25198,"source":{"system":"sec-edgar","filing":"0001567619-21-003626","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921003626/doc1.xml","form_type":"4"}},{"id":2862460,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-12T22:32:40.000Z","date":"2021-02-10","kind":"exercise","acquired":true,"shares":750,"price":1.6806,"value":1260.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,000 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":25948,"source":{"system":"sec-edgar","filing":"0001567619-21-003626","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921003626/doc1.xml","form_type":"4"}},{"id":2880817,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-03T16:23:03.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase."}],"balance_after":46232,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-05-14","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001567619-21-002077","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921002077/doc1.xml","form_type":"4"}},{"id":2880816,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-03T16:23:03.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":3750,"price":35,"value":131250.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by The 1994 Smither Family Trust, as Amended and Restated in 2014, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":89965,"source":{"system":"sec-edgar","filing":"0001567619-21-002077","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921002077/doc1.xml","form_type":"4"}},{"id":2880815,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-03T16:23:03.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":1250,"price":35,"value":43750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,000 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":25198,"source":{"system":"sec-edgar","filing":"0001567619-21-002077","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921002077/doc1.xml","form_type":"4"}},{"id":2880814,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-03T16:23:03.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":1250,"price":1.6806,"value":2100.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,000 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":26448,"source":{"system":"sec-edgar","filing":"0001567619-21-002077","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921002077/doc1.xml","form_type":"4"}},{"id":2900343,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-21T21:41:11.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase."}],"balance_after":47482,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-05-14","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001567619-21-001340","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921001340/doc1.xml","form_type":"4"}},{"id":2900342,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-21T21:41:11.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":1250,"price":30,"value":37500.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by The 1994 Smither Family Trust, as Amended and Restated in 2014, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":93715,"source":{"system":"sec-edgar","filing":"0001567619-21-001340","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921001340/doc1.xml","form_type":"4"}},{"id":2900341,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-21T21:41:11.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":500,"price":30,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,000 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":25198,"source":{"system":"sec-edgar","filing":"0001567619-21-001340","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921001340/doc1.xml","form_type":"4"}},{"id":2900340,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-21T21:41:11.000Z","date":"2021-01-19","kind":"exercise","acquired":true,"shares":500,"price":1.6806,"value":840.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,000 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":25698,"source":{"system":"sec-edgar","filing":"0001567619-21-001340","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761921001340/doc1.xml","form_type":"4"}},{"id":2941941,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-16T20:14:55.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase."}],"balance_after":47982,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-05-14","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001567619-20-021190","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761920021190/doc1.xml","form_type":"4"}},{"id":2941940,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-16T20:14:55.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":3750,"price":30,"value":112500.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are held of record by The 1994 Smither Family Trust, as Amended and Restated in 2014, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":94965,"source":{"system":"sec-edgar","filing":"0001567619-20-021190","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761920021190/doc1.xml","form_type":"4"}},{"id":2941939,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-16T20:14:55.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":1500,"price":30,"value":45000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,000 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,323 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as follows: 1,176 shares on May 31, 2020 and 147 shares on November 30, 2020."}],"balance_after":25198,"source":{"system":"sec-edgar","filing":"0001567619-20-021190","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761920021190/doc1.xml","form_type":"4"}},{"id":2941938,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-16T20:14:55.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":1500,"price":1.6806,"value":2520.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,000 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,323 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as follows: 1,176 shares on May 31, 2020 and 147 shares on November 30, 2020."}],"balance_after":26698,"source":{"system":"sec-edgar","filing":"0001567619-20-021190","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761920021190/doc1.xml","form_type":"4"}},{"id":3018145,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-02T01:00:56.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase."}],"balance_after":49482,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-05-14","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001567619-20-017381","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761920017381/doc1.xml","form_type":"4"}},{"id":3018144,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-02T01:00:56.000Z","date":"2020-09-29","kind":"sale","acquired":false,"shares":1250,"price":30,"value":37500.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by The 1994 Smither Family Trust, as Amended and Restated in 2014, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":98715,"source":{"system":"sec-edgar","filing":"0001567619-20-017381","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761920017381/doc1.xml","form_type":"4"}},{"id":3018143,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-02T01:00:56.000Z","date":"2020-09-29","kind":"sale","acquired":false,"shares":500,"price":30,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,000 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":23875,"source":{"system":"sec-edgar","filing":"0001567619-20-017381","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761920017381/doc1.xml","form_type":"4"}},{"id":3018142,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-02T01:00:56.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":500,"price":1.6806,"value":840.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,000 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":24375,"source":{"system":"sec-edgar","filing":"0001567619-20-017381","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761920017381/doc1.xml","form_type":"4"}},{"id":3110090,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-15T19:15:40.000Z","date":"2020-06-11","kind":"exercise","acquired":false,"shares":14875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects cash exercise of stock option without the disposition of the underlying shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 1/4 of the total shares on May 1, 2020, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on May 1, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase."}],"balance_after":110080,"derivative":{"exercise_price":1.6806,"expiration_date":"2029-05-14","underlying":"Common Stock","underlying_shares":14875},"source":{"system":"sec-edgar","filing":"0001567619-20-012131","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761920012131/doc1.xml","form_type":"4"}},{"id":3110089,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-15T19:15:40.000Z","date":"2020-06-11","kind":"exercise","acquired":true,"shares":14875,"price":1.6806,"value":24998.925,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects cash exercise of stock option without the disposition of the underlying shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,000 Restricted Stock Units (\"RSUs\"). The RSUs vest annually in equal installments over a period of 4 years commencing on the grant date, so that 100% of the RSUs become fully vested on February 27, 2024."}],"balance_after":123840,"source":{"system":"sec-edgar","filing":"0001567619-20-012131","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761920012131/doc1.xml","form_type":"4"}},{"id":3230994,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-04T02:09:30.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the stock option vest in equal monthly installments over a period of 48 months commencing on the grant date so that 100% of the shares become fully vested and exercisable on February 27, 2024."}],"balance_after":12000,"derivative":{"exercise_price":27.61,"expiration_date":"2030-02-27","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-20-005550","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761920005550/doc1.xml","form_type":"4"}},{"id":3230993,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-04T02:09:30.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (\"RSU\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,000 RSUs. The RSUs vest annually in equal installments over a period of 4 years commencing on the grant date, so that 100% of the RSUs become fully vested on February 27, 2024."}],"balance_after":108965,"source":{"system":"sec-edgar","filing":"0001567619-20-005550","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559583/000156761920005550/doc1.xml","form_type":"4"}},{"id":3641227,"issuer":{"id":146423,"kind":"organization","name":"Principia Biopharma Inc.","symbol":"PRNB"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-02-21T18:07:08.000Z","date":"2019-02-19","kind":"grant","acquired":true,"shares":20475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the date of grant, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":20475,"derivative":{"exercise_price":30.3,"expiration_date":"2029-02-18","underlying":"Common Stock","underlying_shares":20475},"source":{"system":"sec-edgar","filing":"0001209191-19-012249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510487/000120919119012249/doc4.xml","form_type":"4"}},{"id":3709050,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2019-01-03T18:19:07.000Z","date":"2019-01-01","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Twenty-five percent (25%) of the shares subject to the option vest and become exercisable on July 1,2019, twenty-five percent (25%) of the shares vest and become exercisable on January 1, 2020, and the remaining shares vest and become exercisable in 12 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":2.32,"expiration_date":"2029-01-01","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001562180-19-000149","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000156218019000149/primarydocument.xml","form_type":"4"}},{"id":3709049,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2019-01-03T18:19:07.000Z","date":"2019-01-01","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty percent (20%) of the shares subject to the option vest and become exercisable upon satisfaction of one performance-based milestone, forty percent (40%) of the shares vest and become exercisable upon satisfaction of a second performance-based milestone, and the remaining forty percent (40%) of the shares vest and become exercisable upon satisfaction of a third performance-based milestone, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":22500,"derivative":{"exercise_price":2.32,"expiration_date":"2029-01-01","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001562180-19-000149","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000156218019000149/primarydocument.xml","form_type":"4"}},{"id":3709048,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2019-01-03T18:19:07.000Z","date":"2019-01-01","kind":"grant","acquired":true,"shares":14422,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14422,"derivative":{"exercise_price":2.32,"exercise_date":"2019-01-01","expiration_date":"2029-01-01","underlying":"Common Stock","underlying_shares":14422},"source":{"system":"sec-edgar","filing":"0001562180-19-000149","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000156218019000149/primarydocument.xml","form_type":"4"}},{"id":3709047,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-03T18:19:07.000Z","date":"2019-01-01","kind":"grant","acquired":true,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Award of restricted stock units (\"RSUs\") granted under the Issuer's 2017 Incentive Award Plan.  Each RSU entitles the Reporting Person to receive one share of Issuer common stock upon vesting.  The award vests as to twenty-five percent (25%) of the total number of RSUs on July 1, 2019, twenty-five percent (25%) of the total number of RSUs on January 1, 2020, and the remaining fifty percent (50%) of the total number of RSUs on the second anniversary, in each case, subject to the Reporting Person's continued employment or service relationship with the Issuer through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes a total of 1,657 shares of the Issuer's common stock acquired pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":46657,"source":{"system":"sec-edgar","filing":"0001562180-19-000149","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000156218019000149/primarydocument.xml","form_type":"4"}},{"id":3866393,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2018-07-17T20:36:33.000Z","date":"2018-07-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":16.9,"exercise_date":"2018-07-15","expiration_date":"2028-07-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-18-003324","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000156218018003324/primarydocument.xml","form_type":"4"}},{"id":3901442,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-07T18:55:26.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":12.07,"expiration_date":"2028-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-18-027771","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301501/000114036118027771/doc1.xml","form_type":"4"}},{"id":3961095,"issuer":{"id":154554,"kind":"organization","name":"Sienna Biopharmaceuticals, Inc.","symbol":"SNNA"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-18T18:31:29.000Z","date":"2018-04-16","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option will vest as follows: i) 20,000 shares subject to the option vest and become exercisable upon satisfaction of a performance-based milestone and ii) 150,000 shares subject to the option vest and become exercisable with respect to 25% of 150,000 shares on the first anniversary measured from April 16, 2018, and the remaining shares subject to the option vest and become exercisable in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":170000,"derivative":{"exercise_price":19.59,"expiration_date":"2028-04-16","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001562180-18-001911","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656328/000156218018001911/primarydocument.xml","form_type":"4"}},{"id":4278898,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-16T17:48:46.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual meeting of stockholders to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":22.11,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-17-025399","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301501/000114036117025399/doc1.xml","form_type":"4"}}]}